Already FDA-approved to treat major depression and migraines, TMS can now be marketed as a treatment for obsessive compulsive disorder Santa Barbara, Calif., September 21, 2018 – Transcranial Magnetic Stimulation (TMS) therapy is rapidly growing in popularity as a treatment [..]
Mood disorders are a national concern that strike one in four adults and, untreated, can dramatically shorten the lifespan of people who suffer from mental illness. Over 60 million Americans suffer from mental illness, the most common of which are anxiety disorders. Over 42 million Americans live with anxiety disorders which include Post Traumatic Stress Disorder (PTSD), obsessive-compulsive disorder (OCD), general anxiety disorder, panic disorder and phobias.
Mood disorders like depression, anxiety and other illnesses are the third leading cause of hospitalization in the U.S. for adults under the age of 45. In addition to suffering from depression, anxiety or other mental illnesses, individuals with severe mood disorders have a higher risk of developing other chronic medical conditions. In fact, people with mental illness die twenty-five (25) years earlier than adults who do not suffer from mental illness – primarily from treatable medical conditions.
Fortunately, advanced treatment options are available—both anxiety treatment and therapy for many mood disorders. Finally, TMS therapy offers hope. If you or a loved one is suffering from depression, anxiety or other mood disorders, do not wait to seek treatment. Contact your physician and get on the path to wellness.